| NCT ID | NCT05687968 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Taipei Medical University |
| Condition | Type 2 Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 39 participants |
| Start Date | 2022-10-19 |
| Primary Completion | 2025-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 39 participants in total. It began in 2022-10-19 with a primary completion date of 2025-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In Taiwan, an estimated 2.3 million individuals have diabetes, with a 44% increase observed among young adults and adolescents. Poor dietary habits and sedentary lifestyles are major risk factors for type 2 diabetes. The widespread use of smartphones has facilitated the development of digital health technologies, including digital food photography and artificial intelligence (AI), which show promise for personalized nutrition care and health promotion. While such technologies have demonstrated short-term success in diabetes management, their long-term effectiveness remains uncertain. This study aims to evaluate the effectiveness of a digital eHealth care intervention for individuals with diabetes. Participants will be recruited from the Diabetes Shared Care Network and community care centers in Taiwan and followed for 12 months. Eligible participants will be randomly assigned by computer to either a control or an eHealth care group. • eHealth Group: Receives a 10-minute digital nutrition education session using the lab-developed "3D/AR MetaFood food portion education platform" (https://sketchfab.com/susanlab108/collections) and is required to submit weekly dietary records through food images using the "Formosa FoodAPP." Participants will receive immediate dietary feedback from nutritionists, followed by AI-generated personalized feedback on the glycemic index (GI) and glycemic load (GL) of their meals. They will also be provided with educational videos on healthy eating, physical activity, and selecting low-GI/GL foods. Anthropometric measurements and baseline questionnaires will be collected at enrollment. Blood biochemistry, including HbA1c, will be measured at baseline, and at 3, 6, 9, and 12 months. Collected food image data will be used to train AI systems for real-time dietary feedback and to explore the relationship between nutrient intake and long-term glycemic control.
Eligibility Criteria
Inclusion Criteria: 1. 20 years old or older 2. Pre-diabetes or diabetes 3. Taiwan nationality or fluent in Mandarin or Taiwanese 4. Not pregnant or breastfeeding 5. Capable (or assisted by a caregiver) of using a smartphone to photograph and record meals Exclusion Criteria: 1. Eating disorders 2. Undergoing treatment for severe illnesses that could affect normal dietary intake (e.g., cancer) 3. Unable to use a smartphone to take photos and record food intake.
Contact & Investigator
Jung-Su Chang, PhD.
PRINCIPAL INVESTIGATOR
College of Nutrition, Taipei Medical University
Frequently Asked Questions
Who can join the NCT05687968 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, studying Type 2 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05687968 currently recruiting?
Yes, NCT05687968 is actively recruiting participants. Contact the research team at susanchang@tmu.edu.tw for enrollment information.
Where is the NCT05687968 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT05687968 clinical trial?
NCT05687968 is sponsored by Taipei Medical University. The principal investigator is Jung-Su Chang, PhD. at College of Nutrition, Taipei Medical University. The trial plans to enroll 39 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.